Blood Count Abnormalities Associated with Death in Patients Infected with SARS-COV-2 at the Ziguinchor EpidemicTreatment Center (ETC) ()
Author(s)
Coly Mame Ngoné1,2*,
Diallo Kalilou3,4,
Sarr Habibou1,2,
Diop Abdoulaye1,4,
Manga Noel Magloire2,3,
Diatta Alassane1,2
Affiliation(s)
1Medical Analysis Laboratory, The Ziguinchor Peace Hospital, Ziguinchor, Senegal.
2Health Sciences Training and Research Unit, The Assane Seck University of Ziguinchor, Ziguinchor, Senegal.
3Infectious Diseases Department, The Ziguinchor Peace Hospital/Ziguinchor Epidemic Treatment Center, Ziguinchor, Senegal.
4Medical Analysis Laboratory, The Ziguinchor Regional Hospital, Ziguinchor, Senegal.
ABSTRACT
Introduction: SARS-COV-2 infection is a real public health challenge for the World Health Organization and for our country. It is responsible for numerous hematological abnormalities in infected patients. Objectives: To describe the haemogram abnormalities in patients infected with SARS-COV-2 and to determine which ones are associated with death. Material and Method: We conducted a retrospective, descriptive, analytical, cross-sectional study from March 2020 to September 2021. The study included all patients hospitalized with RT-PCR-confirmed COVID-19 who performed a blood count. We evaluated the blood count profile, the pathologies found and the associated blood count abnormalities. Results: A total of 263 patients were included. The mean age of the patients was 63.77 years (range 12 - 90 years). The male sex represented 54.75% (n = 144) while the female sex was 45.25% (n = 119) (sex ratio = 1.21). The most common pathologies were: diabetes: 30.03% (n = 79), high blood pressure: 41.04% (n = 108), and Chronic kidney disease: 7.98 (n = 21). The abnormalities of the haemogram found were essential: anaemia 28.13% (n = 121), hyperleukocytosis with neutrophilic predominance: 29.3% (126), lymphopenia: 34.41% (n = 148), thrombocytopenia: 8.16% (n = 35). The search for hematological factors associated with death in patients showed a significant difference between hyperleukocytosis (p = 0.000) and lymphopenia (p = 0.0001). Conclusion: SARS-COV-2 disease was a mortality factor when associated with lymphopenia and hyperleukocytosis in our series.
Share and Cite:
Ngoné, C. , Kalilou, D. , Habibou, S. , Abdoulaye, D. , Magloire, M. and Alassane, D. (2023) Blood Count Abnormalities Associated with Death in Patients Infected with SARS-COV-2 at the Ziguinchor EpidemicTreatment Center (ETC).
Open Journal of Internal Medicine,
13, 304-312. doi:
10.4236/ojim.2023.134028.
Cited by
No relevant information.